000 01226 a2200409 4500
005 20250513191912.0
264 0 _c19990915
008 199909s 0 0 eng d
022 _a0009-9147
040 _aNLM
_beng
_cNLM
100 1 _aRubinacci, A
245 0 0 _aTotal and free deoxypyridinoline after acute osteoclast activity inhibition.
_h[electronic resource]
260 _bClinical chemistry
_cSep 1999
300 _a1510-6 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAmino Acids
_xmetabolism
650 0 4 _aBiomarkers
_xurine
650 0 4 _aBone Resorption
_xurine
650 0 4 _aCalcium
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunoassay
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOsteoclasts
_xmetabolism
650 0 4 _aPeptides
_xmetabolism
650 0 4 _aProtein Binding
650 0 4 _aSensitivity and Specificity
700 1 _aMelzi, R
700 1 _aZampino, M
700 1 _aSoldarini, A
700 1 _aVilla, I
773 0 _tClinical chemistry
_gvol. 45
_gno. 9
_gp. 1510-6
999 _c10429158
_d10429158